|
CO4600681A1
(es)
|
1996-02-24 |
1998-05-08 |
Boehringer Ingelheim Pharma |
Composicion farmaceutica para la modulacion inmunitaria
|
|
DE19803453A1
(de)
|
1998-01-30 |
1999-08-12 |
Boehringer Ingelheim Int |
Vakzine
|
|
EP1061951B1
(en)
*
|
1998-02-25 |
2003-08-27 |
THE GOVERNMENT OF THE UNITED STATES, as represented by THE SECRETARY OF THE ARMY |
Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
|
|
CA2325818C
(en)
*
|
1998-04-20 |
2008-09-02 |
Torrey Pines Institute For Molecular Studies |
Topical immunostimulation to induce langerhans cell migration
|
|
DE60044236D1
(de)
*
|
1999-02-17 |
2010-06-02 |
Csl Ltd |
Immunogene komplexe und methoden in bezug auf diese
|
|
DE19909503A1
(de)
*
|
1999-03-04 |
2000-09-07 |
Boehringer Ingelheim Int |
Tumorassoziiertes Antigen
|
|
US6809179B1
(en)
|
1999-08-04 |
2004-10-26 |
Boehringer Ingelheim International Gmbh |
Tumor-associated antigen (R11)
|
|
AT408721B
(de)
*
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
AT409085B
(de)
*
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US20020009491A1
(en)
*
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT409762B
(de)
*
|
2000-04-13 |
2002-11-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung von zytokin sekretierenden zellen
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
KR20020014459A
(ko)
*
|
2000-08-18 |
2002-02-25 |
서진호 |
양이온성 아미노산이 부가된 융합단백질 및 이를 이용한생물공정의 개선방법
|
|
EP1347775B1
(en)
|
2001-01-05 |
2016-11-30 |
Valneva Austria GmbH |
Uses for polycationic compounds as vaccine adjuvants
|
|
WO2002053185A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Intercell Ag |
Anti-inflammatory use of polycationic compounds
|
|
WO2002053184A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Intercell Ag |
Uses for polycationic compounds as vaccine adjuvants
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
FR2824326B1
(fr)
*
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
US20050250716A1
(en)
*
|
2001-12-07 |
2005-11-10 |
Intercell Ag |
Immunostimulatory oligodeoxynucleotides
|
|
US20050221350A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Toni Weinschenk |
Method for identifying immunoreactive peptides
|
|
JP2005533855A
(ja)
|
2002-07-24 |
2005-11-10 |
インターツェル・アクチェンゲゼルシャフト |
病原性ウイルスからの別のリーディングフレームによりコードされる抗原
|
|
EP1537418A2
(en)
|
2002-09-13 |
2005-06-08 |
Intercell AG |
Method for isolating hepatitis c virus peptides
|
|
JP5116971B2
(ja)
|
2002-10-15 |
2013-01-09 |
インターセル アーゲー |
Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
|
|
CN1756843B
(zh)
|
2003-03-04 |
2012-03-21 |
英特塞尔股份公司 |
化脓链球菌抗原
|
|
AU2004224746B2
(en)
|
2003-03-24 |
2009-04-23 |
Valneva Austria Gmbh |
Improved vaccines
|
|
AU2004226262A1
(en)
|
2003-03-31 |
2004-10-14 |
Intercell Ag |
Staphylococcus epidermidis antigens
|
|
US7635487B2
(en)
|
2003-04-15 |
2009-12-22 |
Intercell Ag |
S. pneumoniae antigens
|
|
EP1620460A2
(en)
|
2003-05-07 |
2006-02-01 |
Intercell AG |
Streptococcus agalactiae antigens i + ii
|
|
EP1629005A2
(en)
|
2003-05-30 |
2006-03-01 |
Intercell AG |
Enterococcus antigens
|
|
CA2530062A1
(en)
|
2003-07-11 |
2005-01-20 |
Intercell Ag |
Hcv vaccines
|
|
EP1722819B1
(en)
|
2004-03-12 |
2007-12-26 |
Intercell AG |
Method for solubilising peptide mixtures
|
|
DE102004038134B4
(de)
|
2004-08-05 |
2013-07-25 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
|
|
EP2149583B1
(en)
|
2004-09-24 |
2015-10-28 |
Novartis AG |
Modified VP1-capsid protein of parvovirus B19
|
|
WO2006045677A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Intercell Ag |
Hcv vaccines for chronic hcv patients
|
|
US7785612B2
(en)
*
|
2005-04-20 |
2010-08-31 |
Taiho Pharmaceutical Co., Ltd. |
Polyamino acid for use as adjuvant
|
|
EP1887084A1
(en)
*
|
2006-08-10 |
2008-02-13 |
International Investment and Patents SA |
Plasmids with immunological action
|
|
EP2289906A1
(en)
|
2006-09-15 |
2011-03-02 |
Intercell AG |
Borrelia antigens
|
|
JP2008174490A
(ja)
*
|
2007-01-18 |
2008-07-31 |
Nitto Denko Corp |
抗原性ペプチドを主成分とする薬剤
|
|
CA2685805A1
(en)
|
2007-05-02 |
2008-11-13 |
Intercell Ag |
Klebsiella antigens
|
|
KR100748265B1
(ko)
*
|
2007-06-15 |
2007-08-10 |
(주)성문엔지니어링 |
공동주택에 배선된 전선의 합선방지구조
|
|
EP2511291A3
(en)
|
2007-06-18 |
2012-11-07 |
Intercell AG |
Chlamydia antigens
|
|
WO2009016639A2
(en)
|
2007-08-02 |
2009-02-05 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope influenza vaccines
|
|
CA2719059C
(en)
*
|
2008-03-27 |
2016-05-17 |
Nestec S.A. |
Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
|
|
JP2012510289A
(ja)
|
2008-12-03 |
2012-05-10 |
プロティア ワクチン テクノロジーズ リミテッド |
グルタミルｔＲＮＡ合成酵素（ＧｔＳ）フラグメント
|
|
EP2405938A2
(en)
|
2009-02-13 |
2012-01-18 |
Intercell AG |
Nontypable haemophilus influenzae antigens
|
|
AU2010288239B2
(en)
*
|
2009-08-27 |
2014-01-16 |
Novartis Ag |
Adjuvant comprising aluminium, oligonucleotide and polycation
|
|
JP5864429B2
(ja)
|
2009-11-09 |
2016-02-17 |
スポットライト テクノロジー パートナーズ エルエルシーＳｐｏｔｌｉｇｈｔ Ｔｅｃｈｎｏｌｏｇｙ Ｐａｒｔｎｅｒｓ Ｌｌｃ |
架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット
|
|
AU2010314994B2
(en)
|
2009-11-09 |
2016-10-06 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
US8765148B2
(en)
|
2010-02-19 |
2014-07-01 |
Valneva Austria Gmbh |
1C31 nanoparticles
|
|
WO2012114323A1
(en)
|
2011-02-22 |
2012-08-30 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
RU2478399C2
(ru)
*
|
2011-06-16 |
2013-04-10 |
Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) |
Способ получения специфического иммуномодулятора
|
|
US20140271723A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Saint Louis University |
Adjuvant compositions and methods of using thereof
|
|
WO2016056596A1
(ja)
|
2014-10-07 |
2016-04-14 |
日本電気株式会社 |
Ｈｓｐ７０由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
|
|
EP3294324A1
(en)
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
CN108368260B
(zh)
*
|
2015-12-16 |
2020-09-29 |
休伯特保健公司 |
含有角鲨烯的基于两亲性聚氨基酸聚合物的疫苗佐剂组合物
|
|
JP6710004B2
(ja)
*
|
2016-03-15 |
2020-06-17 |
Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 |
免疫療法のためのモニタリングまたは診断ならびに治療剤の設計
|
|
EP3735984A1
(en)
*
|
2016-05-27 |
2020-11-11 |
Etubics Corporation |
Neoepitope vaccine compositions and methods of use thereof
|
|
US11291718B2
(en)
*
|
2016-10-11 |
2022-04-05 |
Cytlimic Inc. |
Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
|
|
CN107469067B
(zh)
*
|
2017-09-05 |
2018-06-19 |
浙江大学 |
一种多肽及其改造体在制备免疫调节药物中的应用
|
|
EP3784688A2
(en)
|
2018-04-26 |
2021-03-03 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|
|
CN110870912A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
亚甲蓝类染料作为疫苗佐剂的应用、包含该佐剂的疫苗及其应用
|
|
CN110870913A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗
|
|
CN117860879A
(zh)
*
|
2024-01-10 |
2024-04-12 |
广州医科大学附属肿瘤医院 |
一种纳米疫苗递送系统及其制备方法和应用
|